Serum free indoxyl sulfate associated with in-stent restenosis after coronary artery stentings.
about
Indoxyl Sulfate-Review of Toxicity and Therapeutic StrategiesVasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.Uremic Toxin Clearance and Cardiovascular Toxicities.Gut Microbiota and Cardiovascular Uremic Toxicities
P2860
Serum free indoxyl sulfate associated with in-stent restenosis after coronary artery stentings.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Serum free indoxyl sulfate ass ...... ter coronary artery stentings.
@en
Serum free indoxyl sulfate ass ...... ter coronary artery stentings.
@nl
type
label
Serum free indoxyl sulfate ass ...... ter coronary artery stentings.
@en
Serum free indoxyl sulfate ass ...... ter coronary artery stentings.
@nl
prefLabel
Serum free indoxyl sulfate ass ...... ter coronary artery stentings.
@en
Serum free indoxyl sulfate ass ...... ter coronary artery stentings.
@nl
P2093
P2860
P1476
Serum free indoxyl sulfate ass ...... ter coronary artery stentings.
@en
P2093
Cheng-Chieh Hung
Chun-Chi Chen
I-Chang Hsieh
Ming-Lung Tsai
P2860
P2888
P356
10.1007/S12012-014-9270-2
P577
2015-01-01T00:00:00Z